Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec;35(12):2343-2347.
doi: 10.1002/mds.28244. Epub 2020 Sep 19.

Paroxysmal Cranial Dyskinesia and Nail-Patella Syndrome Caused by a Novel Variant in the LMX1B Gene

Affiliations

Paroxysmal Cranial Dyskinesia and Nail-Patella Syndrome Caused by a Novel Variant in the LMX1B Gene

Sara Bech et al. Mov Disord. 2020 Dec.

Abstract

Background: In a Danish family, multiple individuals in five generations present with early-onset paroxysmal cranial dyskinesia, musculoskeletal abnormalities, and kidney dysfunction.

Objective: To demonstrate linkage and to identify the underlying genetic cause of disease.

Methods: Genome-wide single-nucleotide polymorphisms analysis, Sequence-Tagged-Site marker analyses, exome sequencing, and Sanger sequencing were performed.

Results: Linkage analyses identified a candidate locus on chromosome 9. Exome sequencing revealed a novel variant in LMX1B present in all affected individuals, logarithm of the odds (LOD) score of z = 6.54, predicted to be damaging. Nail-patella syndrome (NPS) is caused by pathogenic variants in LMX1B encoding a transcription factor essential to cytoskeletal and kidney growth and dopaminergic and serotonergic network development. NPS is characterized by abnormal musculoskeletal features and kidney dysfunction. Movement disorders have not previously been associated with NPS.

Conclusions: Paroxysmal dyskinesia is a heretofore unrecognized feature of the NPS spectrum. The pathogenic mechanism might relate to aberrant dopaminergic circuits. © 2020 International Parkinson and Movement Disorder Society.

Keywords: dyskinesia; dystonia; nail-patella syndrome; paroxysmal dyskinesia.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Pedigree. All black indicates the presence of nail‐patella syndrome (NPS) musculoskeletal features and paroxysmal dyskinesia (PxD); black and white indicates musculoskeletal phenotype only. Asterisks (*) indicate availability of SNP6.0 data. The haplotypes for Individuals I‐1, I‐2, and II‐6 are inferred.

References

    1. Mount LA, Reback S. Familial paroxysmal choreoathetosis: preliminary report on a hitherto undescribed clinical syndrome. Arch Neurol Psychiat 1940;44:841–847.
    1. Erro R, Bhatia KP. Unravelling of the paroxysmal dyskinesias. J Neurol Neurosurg Psychiatry 2019;90:227–234. - PubMed
    1. Rohr C, Prestel J, Heidet L, et al. The LIM‐homeodomain transcription factor Lmx1b plays a crucial role in podocytes. J Clin Invest 2002;109(8):1073–1082. - PMC - PubMed
    1. Harita Y, Kitanaka S, Isojima T, Ashida A, Hattori M. Spectrum of LMX1B mutations: from nail–patella syndrome to isolated nephropathy. Pediatr Nephrol 2017;32:1845–1850. - PubMed
    1. Cheng L, Chen CL, Luo P, et al. Lmx1b, Pet‐1, and Nkx2.2 coordinately specify serotonergic neurotransmitter phenotype. J Neurosci 2003;23(31):9961–9967. - PMC - PubMed

Publication types

Substances